Back to the peptide atlas
MitochondriaPeptideNot FDA/EMA approved

MOTS-c

Mitochondrial peptide

Also known as: MOTS-c (Human) · Mitochondrial open reading frame peptide

No account · this device only

The essentials at a glance

Classification
Peptide · Mitochondria
Mechanism
Mitochondrial-derived 16-amino-acid peptide
Evidence
Preclinical
Status
Not FDA/EMA approved

Is studied for cellular energy metabolism, insulin sensitivity, obesity and bone biology.

Distinction: MOTS-c is encoded by mitochondrial DNA, while elamipretide is a synthetic, mitochondria-binding tetrapeptide.

Evidence strengthPreclinical

Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.

Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

Research questions

Mechanism: MOTS-c

01

Mitochondrial peptide

Researchers study how a peptide interacts with the cell's power plants, the mitochondria, and affects their energy production. Measures include oxygen consumption and energy turnover in cell models.

02

Cellular energy metabolism

Researchers study how cells produce and use energy, particularly through the mitochondria, similar to measuring how efficiently an engine burns fuel. Typical measures include oxygen consumption and energy output in cell models.

03

Blood sugar and appetite outcomes

Researchers study how a substance changes blood sugar levels and feelings of hunger over the course of a day, similar to tracking how full someone feels after different meals. Typical measures include blood glucose readings and questionnaires about hunger and food intake.

Simple example

Endogenous repair signal

Think of it like an internal alarm signal that prompts the body toward existing repair processes, similar to a call placed to the body's own repair crew.

Triggering a signal does not automatically mean a predictable or sufficient repair response across the whole organism.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Biohacker and longevity forums

Users compare self-assembled combinations of peptides aimed at influencing ageing processes or energy levels, often based on blood tests or subjective wellbeing scales. Personal self-experiments and marketing promises do not replace controlled long-term human studies.

Energy and fatigue anecdotes

Subjectively perceived increases in energy after using mitochondrial peptides or vitamin injections are reported, often based on personal daily-energy ratings. Such impressions are strongly influenced by placebo effects.

Anti-aging forums

Combinations of growth-axis, mitochondrial, and skin peptides are compared here with the goal of influencing visible or felt signs of ageing, often documented personally over years. Anecdotes and vendor advertising about slowed ageing are not scientific proof.

Evidence boundary

Research is mostly preclinical; statements about humans remain provisional.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.

Primary sources

Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.